Olive Oil Linked to 28% Lower Dementia Death in 92,383 Adults

This 28-year prospective cohort study from Harvard examined the link between olive oil intake and dementia mortality in 92,383 U.S. adults, published in JAMA Network Open. Consuming more than 7 grams per day of olive oil was associated with a 28% lower risk of dementia-related death, with the benefit holding across all diet quality tiers and after adjusting for the APOE epsilon-4 genetic risk allele.

Why This Study Matters

Dementia mortality is rising. The age-standardized death rate from Alzheimer's disease and related dementias has climbed in nearly every high-income country over the last two decades, and pharmaceutical options remain limited. That has pushed dietary research into a more prominent role, and olive oil is one of the more frequently studied components -- but most of the existing evidence ties olive oil to dementia risk through the broader Mediterranean diet, making it hard to isolate the oil's specific contribution.

This study asked a sharper question: independent of overall diet quality, is olive oil intake associated with dementia death? The team used 28 years of follow-up data from the Nurses' Health Study and the Health Professionals Follow-Up Study, tracked dietary intake every four years, and adjusted the analysis for the APOE epsilon-4 allele -- the single strongest genetic risk factor for late-onset Alzheimer's. According to PubMed, the paper was published in JAMA Network Open on May 6, 2024 (DOI: 10.1001/jamanetworkopen.2024.10021).

The result was a 28% lower risk of dementia mortality in the highest olive oil intake category, an effect that held even after layering in the genetic and dietary adjustments. That's a notable finding because most previous work in this area has been confounded by the Mediterranean diet matrix in which olive oil typically appears.

How It Was Designed

The basics are in the study design bar above: 92,383 participants, 28 years of follow-up, two pooled Harvard cohorts, 4,751 dementia-related deaths recorded over 2.18 million person-years.

Dietary intake was assessed by semi-quantitative food frequency questionnaire every four years from 1990 through 2018. The researchers used cumulatively averaged intake rather than baseline-only measurements, which captures actual long-term exposure and reduces measurement error. Olive oil intake was categorized into four bands: never or less than once per month, up to 4.5 g/day, 4.5 to 7 g/day, and more than 7 g/day.

Multivariable Cox proportional-hazards models adjusted for age, ethnicity, BMI, smoking, physical activity, alcohol intake, family history, hypertension, hypercholesterolemia, total energy intake, and -- critically -- the APOE epsilon-4 genotype. APOE epsilon-4 homozygotes were 5 to 9 times more likely to die with dementia in this cohort, so adjusting for it isolates the dietary signal from the dominant genetic risk factor.

The analysis also stratified by overall diet quality using the Alternative Healthy Eating Index and a Mediterranean Diet score. The point was to test whether olive oil's association with dementia mortality survives once you account for the rest of the diet. The substitution analyses modeled what happens when 5 g/day of margarine or mayonnaise is replaced with the equivalent amount of olive oil -- closer to the practical question most readers actually have.

What They Found

Comparing participants in the highest olive oil consumption category (more than 7 g/day) to those who never or rarely consumed olive oil:

Outcome	Hazard Ratio (95% CI)	Risk Reduction	What It Measures
Dementia-related mortality	0.72 (0.64-0.81)	28% lower	Death with dementia as cause
Replace 5 g/d margarine	8-14% lower risk	8-14% lower	Substitution analysis
Replace 5 g/d mayonnaise	8-14% lower risk	8-14% lower	Substitution analysis
P for trend	< 0.001	--	Dose-response significance

Green indicates a favorable direction vs. low/no olive oil intake. The hazard ratio is statistically significant; 95% confidence interval excludes 1.0.

The substitution findings are worth pulling out separately. Swapping 5 g/day of margarine or mayonnaise for olive oil was associated with 8% to 14% lower dementia mortality. Substituting olive oil for butter or for other vegetable oils did not produce a significant effect. This pattern matches what earlier mortality studies have shown: the comparison that drives the benefit is olive oil versus industrial and processed fats, not olive oil versus other plant oils.

Reading the Results

The dose threshold. The dementia mortality benefit emerged at intake levels above 7 g/day -- roughly half a tablespoon. That's a meaningful threshold because it's well below typical Mediterranean-diet consumption (often 30 to 40 g/day) and within reach for most U.S. adults willing to switch their primary cooking fat. The dose-response trend was statistically significant (P for trend less than 0.001).

The APOE adjustment. APOE epsilon-4 is the dominant non-familial genetic risk factor for Alzheimer's disease. Carriers face elevated dementia risk regardless of diet. The fact that the olive oil association held after adjusting for APOE genotype -- and was consistent across carrier and non-carrier subgroups -- suggests the effect is not driven by a quirk in the genetic composition of high-olive-oil consumers. The biological pathway operates on top of, not through, the genetic risk.

The independence from diet quality. The researchers tested whether the association required a high-quality overall diet to manifest. It did not. Higher olive oil intake was associated with lower dementia mortality across all tiers of Alternative Healthy Eating Index and Mediterranean Diet score. That decouples the finding from the broader Mediterranean pattern in a way that earlier studies could not.

The proposed mechanisms. The paper points to several plausible biological pathways for olive oil's effect on neural tissue: hydroxytyrosol and oleocanthal cross the blood-brain barrier and reduce oxidative damage in neurons; oleocanthal has been shown in laboratory studies to bind tau and amyloid-beta proteins; chronic systemic inflammation -- now recognized as a contributor to Alzheimer's and Parkinson's pathology -- is reduced by olive oil polyphenols in controlled trials. None of these mechanisms is proven causal in humans, but each is biologically plausible and consistent with what the cohort data show.

What Didn't Change

Substitution analyses for olive oil versus butter, and olive oil versus other vegetable oils, did not show significant effects on dementia mortality. The cleanest interpretation is that the data support olive oil as superior to highly processed fats (margarine, mayonnaise) for dementia mortality outcomes -- but do not establish it as superior to all other dietary fats.

The study is also observational, not interventional. It cannot prove causation. The associations could reflect residual confounding by overall health-conscious behavior, socioeconomic factors, or unmeasured aspects of diet. The 27-covariate adjustment, the APOE adjustment, and the consistency of the finding across diet quality tiers reduce this concern but do not eliminate it.

Broader Context

This 2024 analysis builds directly on the same Harvard cohorts used in the 2022 Journal of the American College of Cardiology mortality paper, which reported 29% lower neurodegenerative mortality with higher olive oil intake. The 2024 paper drills into dementia mortality specifically, with longer follow-up, more deaths recorded, and the APOE adjustment added. The headline numbers are remarkably consistent across the two analyses.

The PREDIMED trial -- the largest randomized controlled trial of the Mediterranean diet to date -- published a 2018 republished analysis in NEJM showing a 30% reduction in major cardiovascular events with a Mediterranean diet supplemented with extra virgin olive oil. A PREDIMED sub-analysis on cognitive function showed improvements in memory and executive function with the EVOO-supplemented arm. The 2024 Harvard paper extends those findings from cardiovascular endpoints to dementia mortality, and from a Mediterranean cohort to a U.S. cohort.

The 2011 European Food Safety Authority opinion (Regulation 432/2012) authorized a health claim for olive oil polyphenols and protection of blood lipids from oxidative damage at a daily intake of 5 mg of hydroxytyrosol and its derivatives. The EFSA claim is about lipid oxidation, not dementia -- but oxidative stress and inflammation are increasingly understood as upstream drivers of neurodegeneration, which is the mechanistic bridge that connects the two literatures.

Related Research

Continue exploring olive oil and polyphenol science:

• Olive Oil and 19% Lower Mortality in 92,383 U.S. Adults Over 28 Years
• Olive Oil and Brain Health: 66% Lower Cognitive Impairment Risk in PREDIMED Trial
• Olive Oil and 14% Lower CV Risk in 90,000+ US Adults

Source: View the original study on PubMed

Olivea's Dosage

This study identified a dementia mortality benefit beginning above 7 grams per day of olive oil -- roughly half a tablespoon. A single tablespoon of Olivea extra virgin olive oil delivers approximately 14 grams, comfortably above the study threshold. Each Olivea capsule delivers over 20 mg of hydroxytyrosol per serving in an EVOO matrix; our most recent third-party certificate of analysis confirmed 23.5 mg per capsule.

We share this research for transparency. This is an independent study -- we did not fund it, design it, or conduct it.

Editorial Information

Research note. This article summarizes third-party research published in a peer-reviewed journal. Olivea did not conduct or fund the study. Findings reflect the cited paper only and do not establish efficacy of Olivea products.

.